| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/12/2015 | US20150045342 Novel piperidine compound or salt thereof |
| 02/12/2015 | US20150045340 Amidine substituted beta-lactam compounds, their preparation and use as antibacterial agents |
| 02/12/2015 | US20150045338 Methods for treating intrapulmonary infections |
| 02/12/2015 | US20150045337 Controlled release compositions and their methods of use |
| 02/12/2015 | US20150045336 Tazobactam and ceftolozane antibiotic compositions |
| 02/12/2015 | US20150045335 Vaginal inserted estradiol pharmaceutical compositons and methods |
| 02/12/2015 | US20150045333 Liquid compositions comprising vitamin d and uses thereof |
| 02/12/2015 | US20150045332 Novel Sphingosine 1-Phosphate Receptor Antagonists |
| 02/12/2015 | US20150045330 Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor |
| 02/12/2015 | US20150045326 Novel pyrazine amide compounds |
| 02/12/2015 | US20150045324 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
| 02/12/2015 | US20150045322 Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
| 02/12/2015 | US20150045321 Hyaluronic acid based formulations |
| 02/12/2015 | US20150045320 Methods and composition for inducing satiety |
| 02/12/2015 | US20150045318 Component and method for treating viral disease |
| 02/12/2015 | US20150045315 Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound |
| 02/12/2015 | US20150045312 Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome |
| 02/12/2015 | US20150045305 Combination therapies using late sodium ion channel blockers and potassium ion channel blockers |
| 02/12/2015 | US20150045302 Peptides |
| 02/12/2015 | US20150045300 Fast dissolving pharmaceutical composition |
| 02/12/2015 | US20150045297 Growth differentiation factor (gdf) for treatment of diastolic heart failure |
| 02/12/2015 | US20150045292 Methods and composition for inducing satiety |
| 02/12/2015 | US20150045289 Method of pre-preparing medications for therapeutic uses |
| 02/12/2015 | US20150045213 N-cyclylamides as nematicides |
| 02/12/2015 | US20150044314 Pomegranate Oil For Preventing And Treating Neurodegenerative Diseases |
| 02/12/2015 | US20150044313 Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same |
| 02/12/2015 | US20150044309 Antifungal, antibacterial topical composition for the prevention and treatment of various skin conditions including diaper rash |
| 02/12/2015 | US20150044308 Pharmaceutical Composition for Treating Urinary Incontinence and Enuresis |
| 02/12/2015 | US20150044304 Composition for improving neuropsychological test battery score |
| 02/12/2015 | US20150044303 Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them |
| 02/12/2015 | US20150044302 Compositions and methods for promoting appetite suppression using alkali metals |
| 02/12/2015 | US20150044297 Novel galenical system for active transport, method for preparation and use |
| 02/12/2015 | US20150044296 Combination therapy to improve joint, tendon, and ligament healing |
| 02/12/2015 | US20150044295 Combination Product Comprising Phentermine and Topiramate, and Preparation Method Thereof |
| 02/12/2015 | US20150044293 Radioprotector compounds |
| 02/12/2015 | US20150044291 Methods for the treatment of endometriosis |
| 02/12/2015 | US20150044289 Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate |
| 02/12/2015 | US20150044288 Aerosol tyrosine kinase inhibitor compounds and uses thereof |
| 02/12/2015 | US20150044287 Capecitabine rapidly disintegrating tablets |
| 02/12/2015 | US20150044286 Orally disintegrating tablet containing bitterness-masking granules |
| 02/12/2015 | US20150044285 Pharmaceutical soft gelatin capsule dosage form with modified guar gum |
| 02/12/2015 | US20150044284 Dosage form comprising a steroid 5-alpha-reductase inhibitor and an alpha blocker, process for preparing of a dosage form, use of dosage form, method for the treatment or prophylaxis of a disease or condition mediated by androgen |
| 02/12/2015 | US20150044283 Pharmaceutical compositions for the treatment of helicobacter pylori |
| 02/12/2015 | US20150044282 Abuse resistant forms of immediate release oxycodone, method of use and method of making |
| 02/12/2015 | US20150044281 Methods for the treatment of multiple sclerosis and other demyelinating disorders |
| 02/12/2015 | US20150044280 Treatment methods using adenovirus |
| 02/12/2015 | US20150044279 Methods and compositions for enhancing immune response |
| 02/12/2015 | US20150044278 Methods and compositions for the treatment of proliferative disorders |
| 02/12/2015 | US20150044271 Solid drug implants for intracochlear delivery of therapeutics for the treatment of otic disorders |
| 02/12/2015 | US20150044261 Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same |
| 02/12/2015 | US20150044239 Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms |
| 02/12/2015 | US20150044228 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 02/12/2015 | US20150044223 Combination drug therapy for the treatment of solid tumors |
| 02/12/2015 | US20150044220 Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| 02/12/2015 | US20150044219 Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit Tumors and Metastases |
| 02/12/2015 | US20150044217 Methods for the treatment of her2 amplified cancer |
| 02/12/2015 | US20150044211 Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with other anti-tumor compounds |
| 02/12/2015 | US20150044201 Cyclon expression for the identification and control of cancer cells |
| 02/12/2015 | US20150044200 Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system |
| 02/12/2015 | US20150044196 Compositions for Inhibiting Gene Expression and Uses Thereof |
| 02/12/2015 | US20150044193 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION |
| 02/12/2015 | US20150044190 Product and process for liquefaction of mucus or sputum |
| 02/12/2015 | US20150044184 Sirt1 inhibitors and stem cell rejuvenation |
| 02/12/2015 | US20150044174 Composition for improving eye health |
| 02/12/2015 | US20150044173 Microbiota restoration therapy (mrt), compositions and methods of manufacture |
| 02/12/2015 | US20150044169 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
| 02/12/2015 | US20150044149 Aryl substituted propenoic amides and esters |
| 02/12/2015 | US20150044148 Method for Treating Capillary Hemangiomas |
| 02/12/2015 | US20150044147 Composition for management of periodontal disease |
| 02/12/2015 | US20150044145 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion |
| 02/12/2015 | US20150044140 Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs |
| 02/12/2015 | US20150044138 Method for improving functional synaptic connectivity |
| 02/12/2015 | US20150044136 Ophthalmological treatment for michobial infections |
| 02/12/2015 | US20150040894 Aerosolized Dapsone as a Therapy for Inflammation of the Airway and Abnormal Mucociliary Transport |
| 02/12/2015 | DE10340428B4 Opioides Analgetikum enthaltende transdermale Formulierung Opioid analgesic containing transdermal formulation |
| 02/12/2015 | DE102013215435A1 Formulierung enthaltend Caprylsäureethanolamid und/oder Caprinsäureethanolamid in Kombination mit einem Tensid Formulation containing Caprylsäureethanolamid and / or Caprinsäureethanolamid in combination with a surfactant |
| 02/11/2015 | EP2835429A1 Compositions and methods for inhibiting expression of the PCSK9 gene |
| 02/11/2015 | EP2835423A1 Ligase E3 RNF185 inhibitors and uses thereof |
| 02/11/2015 | EP2835372A1 Thiophene [2, 3-d]pyrimidine derivative, and preparation method and use thereof |
| 02/11/2015 | EP2835370A1 New crystals of dabigatran etexilate mesylate |
| 02/11/2015 | EP2835369A1 Crystal form of cabazitaxel and preparation method thereof |
| 02/11/2015 | EP2835367A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/11/2015 | EP2835133A1 Role of N-2-hydroxy-ethyl-piperazine-N'-2-ethane sulfonic acid (HEPES) in reversal of demyelinization injury |
| 02/11/2015 | EP2835131A1 Casein kinase 1delta (CK1delta) inhibitors |
| 02/11/2015 | EP2835053A1 Combination therapy for treating breast cancer |
| 02/11/2015 | EP2834642A1 Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest |
| 02/11/2015 | EP2834258A1 2'- substituted carba-nucleoside analogs for antiviral treatment |
| 02/11/2015 | EP2834255A1 Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation |
| 02/11/2015 | EP2834248A1 Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof |
| 02/11/2015 | EP2834246A1 Combination products with tyrosine kinase inhibitors and their use |
| 02/11/2015 | EP2834245A1 Amino-substituted imidazopyridazines |
| 02/11/2015 | EP2834243A1 PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE |
| 02/11/2015 | EP2834241A1 Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one |
| 02/11/2015 | EP2834240A1 New pyrido [3.4-c][1,9]phenanthroline and 11, 12 dihydropyrido [3.4 -c][1,9]phenanthroline derivatives and the use thereof, particularly for treating cancer |
| 02/11/2015 | EP2834239A1 Heterobicyclic compounds as beta-lactamase inhibitors |
| 02/11/2015 | EP2834238A1 Diacylglycerol acyltransferase 2 inhibitors |
| 02/11/2015 | EP2834234A1 Fused cyclopentyl antagonists of ccr2 |
| 02/11/2015 | EP2834233A1 New alpha2 adrenoceptor agonists |
| 02/11/2015 | EP2834232A1 3,5-diaminopyrazole kinase inhibitors |
| 02/11/2015 | EP2834231A1 Heterocyclic compounds and their uses |